You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • CTV omitted or delineated
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 1, 2023

Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Locally Advanced
  • Non-small Cell Lung Cancer
  • Shanghai, China
    Shanghai Pulmonary Hospital
Mar 14, 2023

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

NSCLC Trial in Jinan (TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation, TQB2450 injection, sequential

Not yet recruiting
  • Non-small Cell Lung Cancer
  • TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation
  • TQB2450 injection, sequential or concurrent chemoradiation
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong First Medical University
May 5, 2023

Locally Advanced Non Small Cell Lung Cancer Patients in Brazil

Completed
  • Lung Cancer, Non-small Cell
    • Salvador, BA, Brazil
    • +10 more
    Jan 5, 2023

    Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

    Not yet recruiting
    • Stage III NSCLC
    • Surgery
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Feb 21, 2023

    Locally Advanced NSCLC, Efficacy and Safety Trial in Guangzhou (Anlotinib, Chemotherapy, Radiotherapy)

    Recruiting
    • Locally Advanced Non-small Cell Lung Cancer
    • Efficacy and Safety
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer Center
    Jul 28, 2022

    NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

    Not yet recruiting
    • Non-small Cell Lung Cancer Stage III
    • radiotherapy
    • +3 more
    • (no location specified)
    Sep 10, 2023

    NSCLC Trial in Tübingen, Münich, Heidelberg (Photons)

    Recruiting
    • Non-small Cell Lung Cancer
    • Photons
    • Tübingen, Baden-Württemberg, Germany
    • +2 more
    Aug 19, 2022

    NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

    Recruiting
    • Non-small Cell Lung Cancer
    • Hypofractionated radiotherapy
    • +4 more
    • Guangzhou, Guangdong, China
      Sun yat-sen university cancer center
    Nov 14, 2023

    Locally Advanced NSCLC, Chemoradiotherapy, Cavitation Lung Trial (Upfront resection)

    Not yet recruiting
    • Locally Advanced Non-Small Cell Lung Cancer
    • +5 more
    • Upfront resection
    • (no location specified)
    Nov 9, 2022

    Toxicity Due to Radiotherapy, NSCLC Trial in Hefei (High-dose fractionated radiotherapy, Low-dose fractionated radiotherapy)

    Recruiting
    • Toxicity Due to Radiotherapy
    • Non-small Cell Lung Cancer
    • High-dose fractionated radiotherapy
    • Low-dose fractionated radiotherapy
    • Hefei, Anhui, China
      Anhui Provicial Hospital
    Mar 7, 2022

    NSCLC, NSCLC Stage III, Recurrent Non Small Cell Lung Cancer Trial (Garmin Vivofit Activity Tracker)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Garmin Vivofit Activity Tracker
    • (no location specified)
    Aug 31, 2022

    Locally Advanced Lung Non-Small Cell Carcinoma Trial in Terni (Stereotactic Ablative Radiotherapy in Unresectable Locally

    Completed
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • Stereotactic Ablative Radiotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
    • Terni, TR, Italy
      Radiotherapy Oncology Centre "S.Maria" Hospital
    Mar 22, 2022

    Radiation Pneumonitis Trial in Zhuhai (Babaodan Capsule)

    Recruiting
    • Radiation Pneumonitis
    • Babaodan Capsule
    • Zhuhai, Guangdong, China
      The Fifth Affiliated Hospital of Sun Yat-sen University
    Oct 8, 2023

    Patients' Whole Process Follow-up Management

    Recruiting
    • Locally Advanced Non-Small Cell Lung Cancer
    • Metastatic NSCLC
    • Patients' whole process follow-up and management platform
    • Jinan, Shandong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Sep 5, 2022

    NSCLC Trial in Guangzhou (BL-M07D1)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 1, 2023

    Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • (no location specified)
    May 8, 2023

    NSCLC Trial in Shanghai (SI-B001, SI-B003)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 10, 2023

    Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life

    Not yet recruiting
    • Brain Metastases
    • Nonsmall Cell Lung Cancer Stage III
    • MRI of the Brain
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Cente
    Jan 19, 2023

    NSCLC Trial in Porto (Durvalumab, standard of care RT/RCT)

    Recruiting
    • Non-small Cell Lung Cancer
    • Porto, Portugal
      Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)
    Feb 23, 2022

    Locally Advanced NSCLC Trial in Beijing (Camrelizumab, PD-1 mAb, Apatinib, VEGFR2 antibody)

    Recruiting
    • Locally Advanced Non-Small Cell Lung Cancer
    • Camrelizumab, PD-1 monoclonal antibody
    • Apatinib, VEGFR2 antibody
    • Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Aug 15, 2022

    Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • Adaptive Radiotherapy
    • +3 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 3, 2022

    NSCLC (NSCLC) Trial in Jinan (WX-0593 Tablets, chemo, Thoracic Radiation Therapy(TRT))

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • WX-0593 Tablets
    • +2 more
    • Jinan, Shandong, China
      Shandong Cancer Hospital and Institute
    Apr 24, 2022